U2AF1 mutations alter sequence specificity of pre-mRNA binding and splicing.

Area of Science:

• Molecular Biology
• Genetics
• Hematology

Background:

• Missense mutations in U2AF1 (S34F, S34Y, Q157R, Q157P) are found in 11% of de novo myelodysplastic syndrome (MDS) patients.
• U2AF1 is a crucial accessory factor in the U2 snRNP complex, but its role in MDS pathophysiology is not fully understood.

Purpose of the Study:

• To investigate how U2AF1 mutations affect splicing patterns.
• To elucidate the molecular mechanisms by which U2AF1 mutations contribute to MDS.

Main Methods:

• RNA sequencing (RNA-seq) on CD34+ hematopoietic cells transfected with mutant U2AF1 (S34F).
• Confirmation of splicing alterations in de novo MDS patient samples.
• Affinity-binding assays to assess U2AF1 binding to RNA sequences.

Main Results:

• Mutant U2AF1 (S34F) expression led to significant differences in known and novel splice junction abundance.
• Splicing alterations were confirmed in primary MDS samples.
• U2AF1 (S34F) showed decreased affinity for uridine at the splice acceptor site's e-3 position.
• U2AF1 (S34F) localization remained normal within nuclear speckles.

Conclusions:

• The S34F mutation impairs U2AF1's RNA binding specificity, leading to aberrant alternative splicing.
• Altered splicing of target genes by mutant U2AF1 may contribute to MDS pathogenesis.